Strata Critical Medical, Inc.
SRTA
$6.03
$0.091.52%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 255.98M | 228.58M | 197.14M | 166.74M | 153.51M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 255.98M | 228.58M | 197.14M | 166.74M | 153.51M |
| Cost of Revenue | 203.36M | 182.17M | 157.80M | 134.05M | 124.92M |
| Gross Profit | 52.62M | 46.41M | 39.34M | 32.69M | 28.58M |
| SG&A Expenses | 53.43M | 53.54M | 51.31M | 52.78M | 55.06M |
| Depreciation & Amortization | 10.72M | 4.45M | 3.37M | 2.02M | 2.02M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 266.61M | 239.25M | 211.58M | 188.28M | 181.40M |
| Operating Income | -10.63M | -10.67M | -14.44M | -21.54M | -27.89M |
| Income Before Tax | -23.16M | -16.05M | -20.07M | -22.11M | -18.08M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -23.16 | -16.05 | -20.07 | -22.11 | -18.08 |
| Earnings from Discontinued Operations | 63.38M | 63.05M | 61.41M | 62.50M | -905.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 40.22M | 46.99M | 41.35M | 40.39M | -18.98M |
| EBIT | -10.63M | -10.67M | -14.44M | -21.54M | -27.89M |
| EBITDA | 4.37M | -1.94M | -7.54M | -16.58M | -22.07M |
| EPS Basic | 0.50 | 0.57 | 0.50 | 0.48 | -0.24 |
| Normalized Basic EPS | -0.04 | -0.03 | -0.05 | -0.13 | -0.18 |
| EPS Diluted | 0.49 | 0.57 | 0.50 | 0.47 | -0.24 |
| Normalized Diluted EPS | -0.04 | -0.03 | -0.05 | -0.13 | -0.18 |
| Average Basic Shares Outstanding | 338.69M | 333.77M | 328.34M | 322.19M | 317.78M |
| Average Diluted Shares Outstanding | 343.54M | 338.62M | 328.34M | 322.19M | 317.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |